project id: TCGA-UCEC; case submitter id: TCGA-EY-A1GM; source center: 23; state: released; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22010; days to death: 995; ethnicity: not reported; gender: female; race: black or african american; vital status: Dead; year of birth: 1950; age at diagnosis: 22010; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 210.0; figo stage: Stage IIIA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 323; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-EY-A1GM-01A-12; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 40.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;